Log in to save to my catalogue

Autologous stem cell transplantation in favorable-risk acute myeloid leukemia: single-center experie...

Autologous stem cell transplantation in favorable-risk acute myeloid leukemia: single-center experie...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2664802495

Autologous stem cell transplantation in favorable-risk acute myeloid leukemia: single-center experience and current challenges

About this item

Full title

Autologous stem cell transplantation in favorable-risk acute myeloid leukemia: single-center experience and current challenges

Publisher

Singapore: Springer Nature Singapore

Journal title

International journal of hematology, 2022-10, Vol.116 (4), p.586-593

Language

English

Formats

Publication information

Publisher

Singapore: Springer Nature Singapore

More information

Scope and Contents

Contents

Background
Autologous stem cell transplantation (ASCT) has gained growing consideration as a treatment option for favorable-risk acute myeloid leukemia (FR-AML) in first complete remission (CR1), compared with chemotherapy.
Materials and Methods
We report the long-term outcomes of 117 consecutive patients with FR-AML fit for intensive chem...

Alternative Titles

Full title

Autologous stem cell transplantation in favorable-risk acute myeloid leukemia: single-center experience and current challenges

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2664802495

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2664802495

Other Identifiers

ISSN

0925-5710

E-ISSN

1865-3774

DOI

10.1007/s12185-022-03370-4

How to access this item